当前位置: 首页 > 期刊 > 《医学信息》 > 2016年第34期
编号:12989520
甲状腺激素在体外循环心脏手术围术期的应用(4)
http://www.100md.com 2016年8月27日 《医学信息》 2016年第34期
     [24]Mackie AS, Booth KL, Newburger JW, et al. A randomized, double-blind, placebo-controlled pilot trial of triiodothyronine in neonatal heart surgery[J]. J Thorac Cardiovasc Surg ,2005, 130(3):810-816.

    [25]Plumpton K, Haas NA. Identifying infants at risk of marked thyroid suppression post-cardiopulmonary bypass[J]. Intensive Care Med ,2005, 31(4):581-587.

    [26]Pantos C, Malliopoulou V, Mourouzis I, et al. Hyperthyroid hearts display a phenotype of cardioprotection against ischemic stress: a possible involvement of heat shock protein 70[J]. Horm Metab Res, 2006 ,38(5):308-313.

    [27]Ranasinghe AM, Quinn DW, Pagano D, et al. Glucose-insulin-potassium and tri-iodothyronine individually improve hemodynamic performance and are associated with reduced troponin I release after on-pump coronary artery bypass grafting[J].Circulation, 2006,114 (Suppl.1) :1245-1250.

    [28]Spratt DI, Frohnauer M, Cyr-Alves H. Physiological effects of nonthyroidal illness syndrome in patients after cardiac surgery[J]. Am J Physiol Endocrinol Metab, 2007, 293(1):E310-315.

    編辑/蔡睿琳, http://www.100md.com(王亚欣 薛玉良)
上一页1 2 3 4